← Evidence map

ArticleSignal transduction and targeted therapy2025

Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair.

Xinyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40634292